医疗耗材和器械

Search documents
英科医疗(300677) - 300677英科医疗投资者关系管理信息20250519
2025-05-19 11:28
Group 1: Financial Performance - In 2024, the company's operating revenue reached CNY 95.23 billion, a year-on-year increase of 282.63% [2] - The net profit attributable to shareholders was CNY 14.65 billion, with a sales price increase of 37.65% compared to the previous year [2][3] - The company's capacity utilization rate was 100% during the reporting period, indicating strong operational efficiency [3] Group 2: Market Dynamics - The U.S. imposes tariffs of 80% on medical-grade nitrile gloves, 55% on industrial-grade nitrile gloves, and 30% on PVC gloves [3] - The U.S. market accounted for approximately 30%-35% of overseas revenue, with European markets growing at a similar pace [3] - The company has been diversifying its market strategy, reducing reliance on the U.S. market since the trade tensions began in 2018 [3] Group 3: Share Buyback and Dividends - As of April 30, 2025, the company repurchased 2,523,900 shares, representing 0.3906% of total equity, with a total expenditure of CNY 53,518,589.28 [4] - The proposed cash dividend for 2024 is approximately CNY 269.61 million, which is 18.40% of the net profit attributable to shareholders [5] - The company plans to maintain sufficient funds to mitigate geopolitical risks and support the establishment of overseas production bases [5]